Cargando…
The challenge of measuring multi-morbidity and its costs
The ageing of the population across developed countries and beyond has increased the importance of examining multi-morbidity. The recent paper by Arbelle et al. [Isr J of Health Policy Res. 2014;3:29] on multiple chronic conditions in Israel’s Maccabi Health Care System (MHC) is a welcome and intere...
Autor principal: | Wittenberg, Raphael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422152/ https://www.ncbi.nlm.nih.gov/pubmed/25949796 http://dx.doi.org/10.1186/2045-4015-4-1 |
Ejemplares similares
-
What do people die from? The challenges of measuring disease burden posed by multi-morbidity
por: McKee, Martin
Publicado: (2015) -
The Impact of Alzheimer's Disease in China
por: Wittenberg, Raphael, et al.
Publicado: (2016) -
The cost-effectiveness challenge: is it worth it?
por: Knapp, Martin
Publicado: (2015) -
Challenges in synthesising cost-effectiveness estimates
por: Shields, Gemma E., et al.
Publicado: (2020) -
It’s X-Related: Biological Bases of Increased COVID-19 Morbidity and Mortality in Men
por: Angelides, Philip K, et al.
Publicado: (2020)